Company Filing History:
Years Active: 2016-2018
Title: Ravindra Mittal: Innovator in Pharmaceutical Compositions
Introduction
Ravindra Mittal is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various medical conditions. With a total of 4 patents to his name, Mittal's work reflects a commitment to enhancing therapeutic efficacy and patient care.
Latest Patents
Mittal's latest patents include innovative pharmaceutical compositions for the treatment of acne. These compositions are designed to be stable and effective, incorporating other pharmaceutically acceptable excipients. They exhibit excellent stability, greater permeability, and enhanced therapeutic efficacy. Another significant patent involves a method for treating pain and inflammation, specifically targeting musculo-skeletal and connective tissue pain. This method aims to reduce the incidence and severity of adverse events associated with the administration of diclofenac, utilizing a topical pharmaceutical composition of diclofenac or its salts.
Career Highlights
Ravindra Mittal is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work at the company has allowed him to focus on developing innovative solutions that address pressing health issues. His contributions have been instrumental in advancing the company's mission to improve patient outcomes through effective medication.
Collaborations
Mittal has collaborated with esteemed colleagues such as Sunilendu Bhushan Roy and Jay Shantilal Kothari. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Ravindra Mittal's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare solutions. His patents reflect a deep understanding of the complexities of treatment and a commitment to enhancing patient care through effective pharmaceutical compositions.